A MULTICENTER, OPEN LABEL, UNCONTROLLED, PHASE II TRIAL EVALUATING SAFETY AND EFFICACY OF VENETOCLAX, ATEZOLIZUMAB ANDOBINUTUZUMAB IN RICHTER TRANSFORMATION FROM CLL. (12th June 2019) - Montillo, M.; Rossi, D.; Zucca, E.; Frustaci, A.M.; Pileri, S.; Cavalli, F.; Tedeschi, A.